Vietnam Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Kinvey Strategy eBook Kinvey answers 7 critical questions about creating your mobile strategy and technology policies. See our answers in this free eBook. From our sponsors

Vietnam Pharmaceuticals and Healthcare Report Q4 2013 Oct 16th 2013, 00:00, by swapnil BMI View: The government’s promise to improve healthcare conditions through rising expenditure will bring potential growth to pharmaceutical firms over the longer term. However, we highlight that there may be a risk of not fulfilling such aims, given extensive bureaucracy and rampant corruption. In addition, the macroeconomic condition was less -than optimistic between Q1 and Q2 this year. Should this continue, it will be challenging for the country to invest in healthcare substantially. Headline Expenditure Projections ? Pharmaceuticals: VND59,214bn (US$2.84bn) in 2012 to VND69,455bn (US$3.32bn) in 2013; +17.3% in local currency terms and +17.1% in US dollar terms. Forecast broadly … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=120659. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/vietnam-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions